Marksans Pharma

{
  "main_header": {
    "sid": 604869,
    "name": "Marksans Pharma",
    "stock_name": "Marksans Pharma",
    "full_name": "Marksans Pharma Ltd",
    "name_url": "stocks-analysis/marksans-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "165.35",
    "chg": 0.45,
    "chgp": "0.27%",
    "dir": 1,
    "prev_price": "164.90",
    "mcapval": "7,545.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524404,
    "symbol": "MARKSANS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE750C01026",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "8.81 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/marksans-pharma-604869-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Marksans Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-sell-3896384",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MarksansPharmaL_mojoScore_3896384.png",
        "date": "2026-03-17 10:10:02",
        "description": "Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 07 July 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 17 March 2026, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Marksans Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-sell-3875693",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MarksansPharmaL_mojoScore_3875693.png",
        "date": "2026-03-06 10:10:02",
        "description": "Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Marksans Pharma Ltd Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-technical-momentum-shifts-amid-bearish-signals-3868194",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MarksansPharmaL_technicaldot_3868194.png",
        "date": "2026-03-04 08:03:42",
        "description": "Marksans Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s recent downgrade from a Hold to a Sell rating reflects growing concerns over its price action and underlying market sentiment, despite its strong long-term returns relative to the Sensex."
      },
      {
        "title": "Marksans Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3863513",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MarksansPharmaL_technicaldot_3863513.png",
        "date": "2026-03-02 08:01:19",
        "description": "Marksans Pharma Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish trends. Despite a recent downgrade in its Mojo Grade to Sell, the stock exhibits a complex interplay of bullish and bearish signals across multiple timeframes, warranting a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Marksans Pharma Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-faces-bearish-momentum-amid-technical-downgrade-3854669",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MarksansPharmaL_technicaldot_3854669.png",
        "date": "2026-02-25 08:02:09",
        "description": "Marksans Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. This change comes alongside a downgrade in the company’s Mojo Grade from Hold to Sell, reflecting growing caution among market participants amid weakening price action and mixed technical signals."
      },
      {
        "title": "Marksans Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-sell-3850551",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MarksansPharmaL_mojoScore_3850551.png",
        "date": "2026-02-23 10:10:51",
        "description": "Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 07 July 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Marksans Pharma Ltd Valuation Shifts to Fair Amidst Sector Comparisons",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-valuation-shifts-to-fair-amidst-sector-comparisons-3841597",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MarksansPharmaL_valuationdot_3841597.png",
        "date": "2026-02-16 08:02:56",
        "description": "Marksans Pharma Ltd has seen a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade as of early 2026. This change reflects evolving market perceptions amid a challenging sector backdrop and a mixed performance relative to peers. Investors are now reassessing the company’s price attractiveness, especially in light of its current price-to-earnings (P/E) and price-to-book value (P/BV) ratios compared to historical averages and industry benchmarks."
      },
      {
        "title": "Marksans Pharma Gains 2.54%: 3 Key Factors Driving the Weekly Move",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-gains-254-3-key-factors-driving-the-weekly-move-3839945",
        "imagepath": "",
        "date": "2026-02-14 16:08:28",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>9 Feb:</strong> Technical downgrade signals bearish momentum</p>\n                    <p><strong>10 Feb:</strong> Mixed technical signals and valuation shift to expensive</p>\n                    <p><strong>13 Feb:</strong> Stock closes lower amid broader market weakness</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.177.15</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.181.65</div><div class=\"stat-change positive\">+2.54%</div></div>\n                    <div class=\"stat-item\"><div ..."
      },
      {
        "title": "Marksans Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-sell-3834945",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MarksansPharmaL_mojoScore_3834945.png",
        "date": "2026-02-12 10:10:26",
        "description": "Marksans Pharma Ltd is rated Sell by MarketsMOJO. This rating was last updated on 07 July 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 12 February 2026, providing investors with the latest insights into its performance and valuation."
      }
    ],
    "total": 335,
    "sid": "604869",
    "stock_news_url": "https://www.marketsmojo.com/news/marksans-pharma-604869"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "12-Mar-2026",
      "details": "Newspaper publication regarding opening of special window for re-lodgement of the transfer request for physical shares",
      "source": "BSE"
    },
    {
      "caption": "Intimation Regarding Opening Of Special Window For Re-Lodgment Of Transfer Requests Of Physical Shares",
      "datetime": "11-Mar-2026",
      "details": "Public notice regarding opening of Special Window for Re-lodgement of Transfer Requests of Physical Shares for information of Shareholders of the Company",
      "source": "BSE"
    },
    {
      "caption": "Investec India Promoter & Founder Conference 2026",
      "datetime": "10-Mar-2026",
      "details": "Officials of the Company will be participating in Investec India Promoter & Founder Conference 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Marksans Pharma Ltd has declared <strong>80%</strong> dividend, ex-date: 01 Aug 25",
          "dt": "2025-08-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Marksans Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Marksans Pharma Ltd is Rated Sell

2026-03-17 10:10:02

Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 07 July 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 17 March 2026, providing investors with the latest insights into its performance and prospects.

Read full news article

Marksans Pharma Ltd is Rated Sell

2026-03-06 10:10:02

Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Marksans Pharma Ltd Technical Momentum Shifts Amid Bearish Signals

2026-03-04 08:03:42

Marksans Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s recent downgrade from a Hold to a Sell rating reflects growing concerns over its price action and underlying market sentiment, despite its strong long-term returns relative to the Sensex.

Read full news article

Marksans Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-03-02 08:01:19

Marksans Pharma Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish trends. Despite a recent downgrade in its Mojo Grade to Sell, the stock exhibits a complex interplay of bullish and bearish signals across multiple timeframes, warranting a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Marksans Pharma Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-02-25 08:02:09

Marksans Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. This change comes alongside a downgrade in the company’s Mojo Grade from Hold to Sell, reflecting growing caution among market participants amid weakening price action and mixed technical signals.

Read full news article

Marksans Pharma Ltd is Rated Sell

2026-02-23 10:10:51

Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 07 July 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Marksans Pharma Ltd Valuation Shifts to Fair Amidst Sector Comparisons

2026-02-16 08:02:56

Marksans Pharma Ltd has seen a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade as of early 2026. This change reflects evolving market perceptions amid a challenging sector backdrop and a mixed performance relative to peers. Investors are now reassessing the company’s price attractiveness, especially in light of its current price-to-earnings (P/E) and price-to-book value (P/BV) ratios compared to historical averages and industry benchmarks.

Read full news article

Marksans Pharma Gains 2.54%: 3 Key Factors Driving the Weekly Move

2026-02-14 16:08:28

Key Events This Week

9 Feb: Technical downgrade signals bearish momentum

10 Feb: Mixed technical signals and valuation shift to expensive

13 Feb: Stock closes lower amid broader market weakness

Week Open

Rs.177.15

Week Close

Rs.181.65

+2.54%

Read full news article

Marksans Pharma Ltd is Rated Sell

2026-02-12 10:10:26

Marksans Pharma Ltd is rated Sell by MarketsMOJO. This rating was last updated on 07 July 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 12 February 2026, providing investors with the latest insights into its performance and valuation.

Read full news article

View All News